3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Midomafetamine: new trials by email Literature Review of Midomafetamine trials Research Report on Midomafetamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD Midomafetamine HCl - PTSD | Phase 3 | Completed | Resilient Pharmaceuticals | 87 | 2021-03-08 | 2025-06-06 |
| A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2) Therapy, Midomafetamine, Placebo - Posttraumatic Stress Disorder | Phase 3 | Completed | Resilient Pharmaceuticals | 121 | 2020-09-02 | 2025-06-06 |
| A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) Therapy, midomafetamine HCl, Placebo - Posttraumatic Stress Disorder | Phase 3 | Completed | Resilient Pharmaceuticals | 100 | 2018-11-21 | 2025-06-06 |
Stress Disorders, Post-Traumatic (3)
Israel (3) · United States (3) · Canada (2)
Bessel van der Kolk, MD (1) · Casey Paleos, MD (1) · Cole Marta, MD (1) · Emma Hapke, MD (1) · Josh Woolley, MD, PhD (1) · Michael Bogenschutz, MD (1) · Randall Brown, MD, PhD (1) · Ray Worthy, MD (1) · Revital Amiaz, MD (1) · Scott Shannon, MD (1) · Sylvestre Quevedo, MD (1) · Wael Garas, MD (1) · Yevgeniy Gelfand, MD (1)